Business Wire

Tecnotree Achieves Impressive Q4 and 2022, and Continues to Enjoy a Strong Order Book Position While Delivering Customer Commitments

Share

Tecnotree, a global digital platform and services leader for 5G and cloud-native technology, today announced its financial results for the fourth quarter and full year of 2022. The company has exceeded its target for 2022 with an 11.5% growth in revenue, showing strong progress in all regions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230224005177/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Tecnotree Achieves Impressive Q4 and 2022, and Continues to Enjoy a Strong Order Book Position While Delivering Customer Commitments (Graphic: Business Wire)

Key Highlights for the full year 2022:

  • Net sales were EUR 71.6 million with a growth of 11.5% as compared to last year.
  • The full-year operating result was EUR 18.3 million, a decrease by 22.7% as compared to last year
  • The net result for the full year was EUR 11.6 (18.3) million, a decrease by 36.7% as compared to year
  • Order book recorded at the end of the year was EUR 68.9 million, showing a 28.8% increase compared to last year
  • Earnings per share were EUR 0.04

Tecnotree CEO, Padma Ravichander, said, “Tecnotree witnessed a surge in demand for its products resulting in another record level order book position. We continued to receive big orders from large tier 1 operators for our Digital BSS Suite 5, which requires that we invest to deliver these orders expeditiously. This will ensure long term recurring revenue from these new customers. Furthermore, as a product company, we witnessed 32% growth in our license revenue, which demonstrates strong trust in Tecnotree and provides credible references to our potential customers. We registered an increase of 7% in recurring revenue compared to the same period last year, which validates the stability of our platform and our ability to rapidly deliver our digital stack to multiple customers simultaneously.”

She further commented, “Tecnotree has set the standard in some respects this year, being the first non-telco in the world to be recognised for Real-World Open APIs by TMForum implementation, which ensures quick and rapid integrations to accelerate business growth and advancement in our partner ecosystems in the 5G and Cloud era. Through its acquisition of the award-winning, and Forrester recognised CognitiveScale platform, Tecnotree has secured 108 granted patents for AIML engineering. This makes Tecnotree a market leader in this space to help further humanise digital experiences with data driven intelligence for its customers across the globe. Tecnotree has also been recognised by Gartner for Customer Experience Management and Revenue Monetisation Management in 2022. In addition, Tecnotree also announced a fast-track global ISV partnership with Microsoft to accelerate the digital transition to cloud with Microsoft Azure.

I want to thank our employees, customers, and shareholders for their continued trust and support, and look forward to building on our momentum as we enter the new year.”

Some other significant milestones and business achievements for the year included:

  • Tecnotree acquired CognitiveScale award-winning AIML platform with 108 granted patents in the United States to further enhance Tecnotree’s AI-enabled total customer experience, creating new prospects in North America
  • The company announced simultaneous production launch of its Digital BSS suite across Europe, the Middle East, and Africa for some of the largest operators, with over 100 million subscribers
  • Tecnotree announced its partnership with MTN Nigeria on a new initiative- Metamorphose Powered by Tecnotree. MTN Metamorphose is a transformation program to enhance the company’s digital presence for consumers and enterprises enabled by Tecnotree’s digital suite.
  • The company was recognized by Gartner® as a representative vendor in the market guide for CSP Revenue Management and Monetization Solutions. Tecnotree’s key investments in the areas of Cloud-based B2B2X ecosystem through Moments, its SaaS offerings that are compatible with the big three clouds (Azure, AWS, GCP), and its Fintech growth through the Diwa platform, led to this recognition
  • Tecnotree acquired several awards including “Change-maker of the year” by the Helsinki Stock Exchange Foundation and the Telco Partner of the Year (ISV) Award from MongoDB

About Tecnotree

Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is among the first companies in the world to be Platinum Certified by TM Forum Open API standards, and our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on Helsinki Nasdaq (TEM1V).

For more information, please visit www.tecnotree.com or social media channels – LinkedIn I Facebook I Twitter I YouTube

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Padma Ravichander, CEO
Email: marketing@tecnotree.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye